4cra: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design== | ==Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design== | ||
<StructureSection load='4cra' size='340' side='right' caption='[[4cra]], [[Resolution|resolution]] 1.80Å' scene=''> | <StructureSection load='4cra' size='340' side='right' caption='[[4cra]], [[Resolution|resolution]] 1.80Å' scene=''> | ||
| Line 6: | Line 7: | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cr5|4cr5]], [[4cr9|4cr9]], [[4crb|4crb]], [[4crc|4crc]], [[4crd|4crd]], [[4cre|4cre]], [[4crf|4crf]], [[4crg|4crg]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cr5|4cr5]], [[4cr9|4cr9]], [[4crb|4crb]], [[4crc|4crc]], [[4crd|4crd]], [[4cre|4cre]], [[4crf|4crf]], [[4crg|4crg]]</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Coagulation_factor_XIa Coagulation factor XIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.27 3.4.21.27] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Coagulation_factor_XIa Coagulation factor XIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.27 3.4.21.27] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cra FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cra OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cra RCSB], [http://www.ebi.ac.uk/pdbsum/4cra PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cra FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cra OCA], [http://pdbe.org/4cra PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4cra RCSB], [http://www.ebi.ac.uk/pdbsum/4cra PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4cra ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| Line 20: | Line 21: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
<div class="pdbe-citations 4cra" style="background-color:#fffaf0;"></div> | |||
==See Also== | |||
*[[Factor XIa|Factor XIa]] | |||
== References == | == References == | ||
<references/> | <references/> | ||